NEW YORK (GenomeWeb News) – Luminex said today that Health Canada has cleared for marketing the firm’s xTAG Respiratory Virus Panel, which detects 18 respiratory viruses and subtypes that are responsible for the majority of respiratory viral infections.

 

The panel is based on Luminex’s xMAP multiplex technology and was developed by the firm’s Toronto-based subsidiary, Luminex Molecular Diagnostics.